Nur Ink Innovations Ltd
TASE:NURI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Nur Ink Innovations Ltd
TASE:NURI
|
IL |
|
S
|
Sansuy SA Industria de Plasticos em Recuperacao Judicial
BOVESPA:SNSY5
|
BR |
Balance Sheet
Balance Sheet Decomposition
Nur Ink Innovations Ltd
Nur Ink Innovations Ltd
Balance Sheet
Nur Ink Innovations Ltd
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
1
|
0
|
33
|
12
|
2
|
1
|
4
|
|
| Cash Equivalents |
1
|
0
|
33
|
12
|
2
|
1
|
4
|
|
| Short-Term Investments |
0
|
0
|
0
|
10
|
8
|
4
|
0
|
|
| Total Receivables |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Accounts Receivables |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
1
|
34
|
22
|
11
|
6
|
5
|
|
| PP&E Net |
1
|
1
|
7
|
8
|
7
|
7
|
6
|
|
| PP&E Gross |
1
|
1
|
7
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
1
|
4
|
3
|
8
|
11
|
|
| Total Assets |
2
N/A
|
1
-15%
|
41
+3 000%
|
33
-19%
|
22
-34%
|
21
-2%
|
23
+6%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
1
|
0
|
0
|
1
|
1
|
1
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
2
|
2
|
1
|
2
|
2
|
2
|
|
| Long-Term Debt |
0
|
0
|
4
|
3
|
3
|
2
|
2
|
|
| Other Liabilities |
0
|
0
|
0
|
1
|
1
|
2
|
2
|
|
| Total Liabilities |
0
N/A
|
2
+577%
|
5
+124%
|
5
+4%
|
6
+5%
|
7
+14%
|
6
-11%
|
|
| Equity | ||||||||
| Common Stock |
0
|
0
|
49
|
51
|
51
|
59
|
70
|
|
| Retained Earnings |
2
|
6
|
14
|
26
|
38
|
48
|
58
|
|
| Additional Paid In Capital |
3
|
5
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
1
|
0
|
3
|
4
|
4
|
4
|
|
| Total Equity |
1
N/A
|
1
N/A
|
36
N/A
|
28
-22%
|
16
-42%
|
15
-8%
|
17
+14%
|
|
| Total Liabilities & Equity |
2
N/A
|
1
-15%
|
41
+3 000%
|
33
-19%
|
22
-34%
|
21
-2%
|
23
+6%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
5
|
5
|
5
|
5
|
5
|
6
|
8
|
|